BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28789433)

  • 61. Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression.
    Wu CS; Yen CJ; Chou RH; Chen JN; Huang WC; Wu CY; Yu YL
    Int J Cancer; 2014 Apr; 134(7):1638-47. PubMed ID: 24122375
    [TBL] [Abstract][Full Text] [Related]  

  • 62. USP16 Downregulation by Carboxyl-terminal Truncated HBx Promotes the Growth of Hepatocellular Carcinoma Cells.
    Qian Y; Wang B; Ma A; Zhang L; Xu G; Ding Q; Jing T; Wu L; Liu Y; Yang Z; Liu Y
    Sci Rep; 2016 Sep; 6():33039. PubMed ID: 27633997
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Peroxiredoxin 1, a Novel HBx-Interacting Protein, Interacts with Exosome Component 5 and Negatively Regulates Hepatitis B Virus (HBV) Propagation through Degradation of HBV RNA.
    Deng L; Gan X; Ito M; Chen M; Aly HH; Matsui C; Abe T; Watashi K; Wakita T; Suzuki T; Okamoto T; Matsuura Y; Mizokami M; Shoji I; Hotta H
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30567989
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comprehensive analysis of long non-coding RNA expression profiles in hepatitis B virus-related hepatocellular carcinoma.
    Gong X; Wei W; Chen L; Xia Z; Yu C
    Oncotarget; 2016 Jul; 7(27):42422-42430. PubMed ID: 27285756
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hepatitis B virus X protein promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cell line HCCLM3 by targeting HMGA2.
    Zha Y; Yao Q; Liu JS; Wang YY; Sun WM
    Oncol Lett; 2018 Nov; 16(5):5709-5714. PubMed ID: 30356986
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.
    Park IY; Sohn BH; Yu E; Suh DJ; Chung YH; Lee JH; Surzycki SJ; Lee YI
    Gastroenterology; 2007 Apr; 132(4):1476-94. PubMed ID: 17408664
    [TBL] [Abstract][Full Text] [Related]  

  • 68. HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma.
    Qiu X; Dong S; Qiao F; Lu S; Song Y; Lao Y; Li Y; Zeng T; Hu J; Zhang L; Zhang L; Fan H
    Oncogene; 2013 Jul; 32(27):3296-305. PubMed ID: 23604124
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long Non-Coding RNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Regulation, Functions, and Underlying Mechanisms.
    Qiu L; Wang T; Xu X; Wu Y; Tang Q; Chen K
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29168767
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The viral oncoprotein HBx of Hepatitis B virus promotes the growth of hepatocellular carcinoma through cooperating with the cellular oncoprotein RMP.
    Wang Q; Xu Y; Zhou W; Zhong L; Wen Z; Yu H; Chen S; Shen J; Chen H; She Q; Jiang J; Miao J; Wei W
    Int J Biol Sci; 2014; 10(10):1181-92. PubMed ID: 25516716
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The regulation of proteins associated with the cytoskeleton by hepatitis B virus X protein during hepatocarcinogenesis.
    Kong F; You H; Tang R; Zheng K
    Oncol Lett; 2017 Apr; 13(4):2514-2520. PubMed ID: 28454428
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hepatitis B virus replicating in hepatocellular carcinoma encodes HBx variants with preserved ability to antagonize restriction by Smc5/6.
    Rivière L; Quioc-Salomon B; Fallot G; Halgand B; Féray C; Buendia MA; Neuveut C
    Antiviral Res; 2019 Dec; 172():104618. PubMed ID: 31600532
    [TBL] [Abstract][Full Text] [Related]  

  • 73. HBx-induced androgen receptor expression in HBV-associated hepatocarcinoma is independent of the methylation status of its promoter.
    Zhu R; Zhang JS; Zhu YZ; Fan J; Mao Y; Chen Q; Zhu HG
    Histol Histopathol; 2011 Jan; 26(1):23-35. PubMed ID: 21117024
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hepatitis B virus X protein stabilizes amplified in breast cancer 1 protein and cooperates with it to promote human hepatocellular carcinoma cell invasiveness.
    Liu Y; Tong Z; Li T; Chen Q; Zhuo L; Li W; Wu RC; Yu C
    Hepatology; 2012 Sep; 56(3):1015-24. PubMed ID: 22473901
    [TBL] [Abstract][Full Text] [Related]  

  • 75. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway.
    Ching RHH; Sze KMF; Lau EYT; Chiu YT; Lee JMF; Ng IOL; Lee TKW
    Oncotarget; 2017 Apr; 8(14):23507-23516. PubMed ID: 28186991
    [TBL] [Abstract][Full Text] [Related]  

  • 76. HBV suppresses ZHX2 expression to promote proliferation of HCC through miR-155 activation.
    Song X; Tan S; Wu Z; Xu L; Wang Z; Xu Y; Wang T; Gao C; Gong Y; Liang X; Gao L; Spear BT; Ma C
    Int J Cancer; 2018 Dec; 143(12):3120-3130. PubMed ID: 29752719
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hepatitis B virus X protein promotes the stem-like properties of OV6
    Wang C; Wang MD; Cheng P; Huang H; Dong W; Zhang WW; Li PP; Lin C; Pan ZY; Wu MC; Zhou WP
    Cell Death Dis; 2017 Jan; 8(1):e2560. PubMed ID: 28102846
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma.
    Kew MC
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():144-52. PubMed ID: 21199526
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mechanism of HBx carcinogenesis interaction with non-coding RNA in hepatocellular carcinoma.
    Wang Z; Li N; Cai P; Zhang C; Cao G; Yin J
    Front Oncol; 2023; 13():1249198. PubMed ID: 37746253
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hepatitis B virus-X protein regulates high mobility group box 1 to promote the formation of hepatocellular carcinoma.
    Wu D; Liang H; Wang H; Duan C; Yazdani H; Zhou J; Pan Y; Shan B; Su Z; Wei J; Cui T; Tai S
    Oncol Lett; 2018 Oct; 16(4):4418-4426. PubMed ID: 30214576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.